PMS2 inhibitor NP1867 cysteinome adduction by cell-based proteomincs

ABSTRACT: MMR protein PMS2 is a druggable target. Discovery and characterisation of first-in-class small molecule MMR pathway modulator NP1867.

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Permanent Cell Line Cell, Cell Culture

DISEASE(S): Colon Cancer

SUBMITTER: Alexia Hervieu  

LAB HEAD: Rob Howes,

PROVIDER: PXD077673 | Pride | 2026-04-28

REPOSITORIES: Pride